Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 84% ± 18% | |
peripheral blood | 19 studies | 92% ± 12% | |
brain | 14 studies | 43% ± 20% | |
intestine | 13 studies | 90% ± 15% | |
eye | 10 studies | 66% ± 21% | |
kidney | 8 studies | 82% ± 21% | |
liver | 7 studies | 70% ± 23% | |
bone marrow | 6 studies | 91% ± 10% | |
pancreas | 5 studies | 86% ± 17% | |
uterus | 5 studies | 93% ± 11% | |
lymph node | 4 studies | 99% ± 1% | |
placenta | 4 studies | 87% ± 21% | |
heart | 4 studies | 46% ± 19% | |
adipose | 4 studies | 58% ± 26% | |
esophagus | 4 studies | 76% ± 23% | |
prostate | 4 studies | 89% ± 19% | |
breast | 4 studies | 97% ± 3% | |
skin | 3 studies | 90% ± 11% | |
stomach | 3 studies | 71% ± 17% | |
thymus | 3 studies | 77% ± 33% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 38084.95 | 21 / 21 | 100% | 964.40 | 504 / 504 |
esophagus | 100% | 34672.33 | 1445 / 1445 | 100% | 601.94 | 183 / 183 |
ovary | 100% | 78922.30 | 180 / 180 | 100% | 991.28 | 430 / 430 |
pancreas | 100% | 37909.82 | 328 / 328 | 100% | 903.00 | 178 / 178 |
prostate | 100% | 40324.25 | 245 / 245 | 100% | 1493.38 | 502 / 502 |
skin | 100% | 53627.17 | 1809 / 1809 | 100% | 948.58 | 472 / 472 |
stomach | 100% | 38041.38 | 359 / 359 | 100% | 831.30 | 286 / 286 |
thymus | 100% | 33358.40 | 653 / 653 | 100% | 1210.87 | 605 / 605 |
uterus | 100% | 45121.75 | 170 / 170 | 100% | 1157.02 | 459 / 459 |
lung | 100% | 32690.28 | 577 / 578 | 100% | 790.78 | 1155 / 1155 |
intestine | 100% | 36378.67 | 966 / 966 | 100% | 978.53 | 526 / 527 |
kidney | 100% | 30013.97 | 89 / 89 | 100% | 720.76 | 899 / 901 |
breast | 100% | 52562.19 | 459 / 459 | 100% | 943.62 | 1115 / 1118 |
liver | 100% | 16826.95 | 226 / 226 | 99% | 562.07 | 402 / 406 |
brain | 99% | 14265.57 | 2606 / 2642 | 100% | 594.58 | 704 / 705 |
adrenal gland | 100% | 27825.48 | 258 / 258 | 95% | 430.72 | 219 / 230 |
adipose | 100% | 47162.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 1322.90 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1856.50 | 29 / 29 |
spleen | 100% | 42121.19 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 925.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 650.64 | 1 / 1 |
blood vessel | 100% | 32128.13 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 19207.02 | 791 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 19381.72 | 845 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 76% | 24552.21 | 707 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901798 | Biological process | positive regulation of signal transduction by p53 class mediator |
GO_0032435 | Biological process | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_2000059 | Biological process | negative regulation of ubiquitin-dependent protein catabolic process |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0006412 | Biological process | translation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0000027 | Biological process | ribosomal large subunit assembly |
GO_0006605 | Biological process | protein targeting |
GO_2000435 | Biological process | negative regulation of protein neddylation |
GO_0042273 | Biological process | ribosomal large subunit biogenesis |
GO_0050821 | Biological process | protein stabilization |
GO_0034504 | Biological process | protein localization to nucleus |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_1904667 | Biological process | negative regulation of ubiquitin protein ligase activity |
GO_0006364 | Biological process | rRNA processing |
GO_0002181 | Biological process | cytoplasmic translation |
GO_0005730 | Cellular component | nucleolus |
GO_0022626 | Cellular component | cytosolic ribosome |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0022625 | Cellular component | cytosolic large ribosomal subunit |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990948 | Molecular function | ubiquitin ligase inhibitor activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0008097 | Molecular function | 5S rRNA binding |
GO_0003735 | Molecular function | structural constituent of ribosome |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RPL11 |
Protein name | Ribosomal protein L11 Large ribosomal subunit protein uL5 (60S ribosomal protein L11) Large ribosomal subunit protein uL5 (60S ribosomal protein L11) (CLL-associated antigen KW-12) |
Synonyms | hCG_1739238 |
Description | FUNCTION: Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell . The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules . The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by tRNAs into a polypeptide chain . The nascent polypeptides leave the ribosome through a tunnel in the LSU and interact with protein factors that function in enzymatic processing, targeting, and the membrane insertion of nascent chains at the exit of the ribosomal tunnel . As part of the 5S RNP/5S ribonucleoprotein particle it is an essential component of the LSU, required for its formation and the maturation of rRNAs . It also couples ribosome biogenesis to p53/TP53 activation. As part of the 5S RNP it accumulates in the nucleoplasm and inhibits MDM2, when ribosome biogenesis is perturbed, mediating the stabilization and the activation of TP53 . Promotes nucleolar location of PML (By similarity). . |
Accessions | Q5VVD0 ENST00000458455.2 A0A2R8Y447 ENST00000374550.8 [P62913-2] Q5VVC8 ENST00000467075.2 ENST00000643754.2 [P62913-1] P62913 |